Chitosan/pshRNA plasmid nanoparticles targeting MDR1 gene reverse paclitaxel resistance in ovarian cancer cells

Abstract

In order to investigate the effect of chitosan/pshRNA plasmid nanoparticles targeting MDR1 genes on the resistance of A2780/TS cells to paclitaxel, chitosan/pshRNA plasmid nanoparticles were synthesized by means of a complex coacervation technique and transfected into A2780/TS cells. The cells transfected with MDR1-targeted chitosan/pshRNA plasmid nanoparticles were experimental cells and the cells transfected with chitosan/pGPU6/GFP/Neo no-load plasmid nanoparticles served as negative control cells. Morphological features of the nanoparticles were observed under transmission electron microscope (TEM). MDR1 mRNA expression was assessed by RT-PCR. Half-inhibitory concentration (IC₅₀) of paclitaxel for A2780/TS cells was determined by MTT method. TEM showed that the nanoparticles were round-shaped, smooth in surface and the diameters varied from 80 to 120 nm. The MDR1 mRNA in the transfected cells was significantly decreased by 17.6%, 27.8% and 52.6% on the post-transfection day 2, 4 and 7 when compared with that in A2780/TS cells control (P<0.05). MTT assay revealed that the relative reversal efficiency was increased over time and was 29.6%, 51.2% and 61.3% respectively in the transfected cells 2, 4, 7 days after transfection and IC₅₀ (0.197±0.003, 0.144±0.001, 0.120±0.004) were decreased with difference being significant when compared with that in A2780/TS (0.269±0.003) cells control (P<0.05). It was concluded that chitosan/pshRNA plasmid nanoparticles targeting MDR1 can effectively reverse the paclitaxel resistance in A2780/TS cells in a time-dependent manner.

Keywords

MDR1 gene / chitosan / pshRNA / ovarian cancer / paclitaxel / drug resistance

References

[1] YusufR.Z., DuanZ., LamendolaD.E., et al. . Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation. Curr Cancer Drug Targets, 2003, 3(1): 1-19

[2] EndicottJ.A., LingV.. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem, 1989, 58: 137-171

[3] HaoW., WilliamN., JinmingY.. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res, 2003, 63(7): 1515-1519

[4] XiaoL., GaoR., LuS., et al. . Reversal of adriamycin resistance in human mammary cancer cells by small interfering RNA of MDR1 and MDR3 genes. J Huazhong Univ Sci Technol Med Sci, 2006, 26(6): 735-737

[5] ChenX.P., WangQ., GuanJ., et al. . Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells. World J Gastroenterol, 2006, 12(21): 3332-3337

[6] ShiZ., LiangY.L., ChenZ.S., et al. . Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector- based RNA interference in vitro and in vivo. Cancer Biol Ther, 2006, 5(1): 39-47

[7] GanH.Z., ZhangG.Z., ZhaoJ.S., et al. . Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Chin Med J (Engl), 2005, 118(11): 893-902

[8] KobayashiN., MatsuiY., KawaseA., et al. . Vector-based in vivo RNA interference: dose- and time-dependent suppression of transgene expression. J Pharmacol Ther, 2004, 308(2): 688-693

[9] TajikH., MaradiM., RohaniS.M., et al. . Preparation of chitosan from brine shrimp (Artemia urmiana) cyst shells and effects of different chemical processing sequences on the physicochemical and functional properties of the product. Molecules, 2008, 13(6): 1263-1274

[10] MaoH.Q., RoyK., Troung-LeV.L., et al. . Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Controlled Release, 2001, 70(3): 399-421

[11] GuliyevaU., OnerF., OzsoyS., et al. . Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. Eur J Pharm Biopharm, 2006, 62(1): 17-25

[12] XuC., CaiH., XuQ., et al. . Characterization of single-stranded DNA on chitosan-modified electrode and its application to the sequence-specific DNA detection. Fresenius J Anal Chem, 2001, 369(5): 428-432

[13] VenkateshS., SmithT.J.. Chitosan-membrane interaction and their probable role in chitosan-mediated transfection. Biotechnol Appl Biochem, 1998, 27(3): 265-267

[14] StavrovskayaA.A., AtromskayaT.P.. Transport proteins of the ABC family and multidrug resistance of tumor cells. Biochemistry (Mosc), 2008, 73(5): 592-604

[15] LageH.. MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. Curr Drug Targets, 2006, 7(7): 813-821

[16] AaqaardL., RossiJ.J.. RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev, 2007, 59(2–3): 75-86

[17] YouJ.O., LiuY.C., PengC.A.. Efficient gene transfection using chitosan-alginate core-shell nanoparticles. Int J Nanomedicine, 2006, 1(2): 173-180

[18] DaiH., JiangX., TanG.C., et al. . Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine, 2006, 1(4): 507-522

[19] MansouriS., LavigneP., CorsiK., et al. . Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficiency. Eur J Pharm Biopharm, 2004, 57(1): 1-8

[20] BorchardG.. Chtosans for gene delivery. Adv Drug Deliv Rev, 2001, 52(2): 145-150

[21] MansouriS., LaviqneP., CorsiK., et al. . Chitosan-DNA nanoparticles as non-viral vectors in gene therapy. Strategies to improve transfection efficiency. Eur J Pharm Biopharm, 2004, 57(1): 1-8

[22] WanY.Y., ZhangX., HeY.J., et al. . Feasibility of chitosan as gene therapy vehicle. Ai Zheng, 2005, 24(11): 1408-1411

[23] TugceD., KadirT.. In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells. J Pharm Pharmaceut Sci, 2004, 7(2): 205-214

[24] QingQ.Z., JinL.C., MinH., et al. . Combination of poly (ethylenimine) and chitosan induces high gene transfection efficiency and low cytotoxicity. J Bioscience Bioengineering, 2008, 105(1): 65-68

[25] LiC.X., ParkerA., MenocalE., et al. . Delivery of RNA interference. Cell Cycle, 2006, 5(18): 2103-2109

[26] HalizaK.H., OyaA.. Development and characterization of chitosan nanoparticles for siRNA delivery. J Control Release, 2006, 115(2): 216-225